Angiogenesis and hepatocellular carcinoma

被引:314
作者
Semela, D [1 ]
Dufour, JF [1 ]
机构
[1] Univ Bern, Inst Clin Pharmacol, CH-3010 Bern, Switzerland
关键词
D O I
10.1016/j.jhep.2004.09.006
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
[No abstract available]
引用
收藏
页码:864 / 880
页数:17
相关论文
共 236 条
[111]   Prospective randomized controlled study of interferon-alpha in preventing hepatocellular carcinoma recurrence after medical ablation therapy for primary tumors [J].
Lin, SM ;
Lin, CJ ;
Hsu, CW ;
Tai, DI ;
Sheen, IS ;
Lin, DY ;
Liaw, YF .
CANCER, 2004, 100 (02) :376-382
[112]   Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival [J].
Llovet, JM ;
Bruix, J .
HEPATOLOGY, 2003, 37 (02) :429-442
[113]  
Logothetis CJ, 2001, CLIN CANCER RES, V7, P1198
[114]   Anti-angiogenic therapy: Rationale, challenges and clinical studies [J].
Longo R. ;
Sarmiento R. ;
Fanelli M. ;
Capaccetti B. ;
Gattuso D. ;
Gasparini G. .
Angiogenesis, 2002, 5 (4) :237-256
[115]   Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth [J].
Lyden, D ;
Hattori, K ;
Dias, S ;
Costa, C ;
Blaikie, P ;
Butros, L ;
Chadburn, A ;
Heissig, B ;
Marks, W ;
Witte, L ;
Wu, Y ;
Hicklin, D ;
Zhu, ZP ;
Hackett, NR ;
Crystal, RG ;
Moore, MAS ;
Hajjar, KA ;
Manova, K ;
Benezra, R ;
Rafii, S .
NATURE MEDICINE, 2001, 7 (11) :1194-1201
[116]   Tumstatin, an endothelial cell-specific inhibitor of protein synthesis [J].
Maeshima, Y ;
Sudhakar, A ;
Lively, JC ;
Ueki, K ;
Kharbanda, S ;
Kahn, CR ;
Sonenberg, N ;
Hynes, RO ;
Kalluri, R .
SCIENCE, 2002, 295 (5552) :140-143
[117]  
Mahasreshti PJ, 2003, CLIN CANCER RES, V9, P2701
[118]   AIDS-related Kaposi's sarcoma cells rapidly internalize endostatin, which co-localizes to tropomysin microfilaments and inhibits cytokine-mediated migration and invasion [J].
Mallery, SR ;
Morse, MA ;
Wilson, RF ;
Pei, P ;
Ness, GM ;
Bradburn, JE ;
Renner, RJ ;
Schuller, DE ;
Robertson, FM .
JOURNAL OF CELLULAR BIOCHEMISTRY, 2003, 89 (01) :133-143
[119]   Phase Ib trial of intravenous recombinant humanized monoclonal antibody to vascular endothelial growth factor in combination with chemotherapy in patients with advanced cancer: Pharmacologic and long-term safety data [J].
Margolin, K ;
Gordon, MS ;
Holmgren, E ;
Gaudreault, J ;
Novotny, W ;
Fyfe, G ;
Adelman, D ;
Stalter, S ;
Breed, J .
JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (03) :851-856
[120]   Successful antiangiogenic therapy of giant cell angioblastoma with interferon alfa 2b: Report of 2 cases [J].
Marler, JJ ;
Rubin, JB ;
Trede, NS ;
Connors, S ;
Grier, H ;
Upton, J ;
Mulliken, JB ;
Folkman, J .
PEDIATRICS, 2002, 109 (02) :E37